טוען...
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Monoclonal antibodies (mAb) are revolutionising the treatment of many different diseases. Given their differing mode of action compared to most conventional chemotherapeutics and small molecule inhibitors, they possess the potential to be independent of common modes of treatment resistance and can t...
שמור ב:
| הוצא לאור ב: | J Clin Immunol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4891381/ https://ncbi.nlm.nih.gov/pubmed/26922075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-016-0247-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|